Litigation Details for SUPERNUS PHARMACEUTICALS, INC. v. ACTAVIS INC. (D.N.J. 2015)
✉ Email this page to a colleague
SUPERNUS PHARMACEUTICALS, INC. v. ACTAVIS INC. (D.N.J. 2015)
| Docket | ⤷ Try a Trial | Date Filed | 2015-04-07 |
| Court | District Court, D. New Jersey | Date Terminated | 2016-05-04 |
| Cause | 35:271 Patent Infringement | Assigned To | Renee Marie Bumb |
| Jury Demand | None | Referred To | Joel Schneider |
| Patents | 8,821,930 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in SUPERNUS PHARMACEUTICALS, INC. v. ACTAVIS INC.
The small molecule drug covered by the patent cited in this case is ⤷ Try a Trial .
Details for SUPERNUS PHARMACEUTICALS, INC. v. ACTAVIS INC. (D.N.J. 2015)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2015-04-07 | 1 | Code, involving United States Patent No. 8,821,930 (“the ’930 patent”), attached hereto as Exhibit A… This is a civil action for patent infringement arising under the patent laws of the United States, … in the ’930 patent. 25. Pursuant to 21 U.S.C. § 355(b)(1), the ’930 patent is listed in …the ’930 patent is an act of infringement by Defendants of one or more claims of the ’930 patent under … COMPLAINT FOR PATENT v. | External link to document | |
| 2015-04-30 | 7 | under the patent laws of the United States, and that a copy of United States Patent No. 8,821,930 (“the …Defendant") that United States Patent No. 8,821,930 (the “’930 patent”) is not infringed by the proposed…valid claim of the ’930 Patent. 41. The claims of the ’930 Patent insofar as they may relate… the ’930 patent are invalid for failing to meet one or more requirements for patentability of Title …claim of the ’930 Patent; C. Declaring that the claims of the ’930 Patent, insofar as they | External link to document | |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
